Replies to post #85953 on Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

95% probability that the company will partner with Becton Dickinson to commercialize LymPro in the United States. 5% probability that another "big pharma" drug company such as J & J would be the partner.

0% probability that AMBS would commercialize "LymPro" on its own.

Sanofi in the E.U. and Takeda in Asia.

All IMHO.

[Riskreturn168]

I think Gerald has the money from financing to continue advancing LymPro and a few MANF indications for the next several months, without having to accept partnerships that he considers too low. He is in the fortunate position of being able to wait until he gets the right offer. But regarding LymPro, I doubt he would attempt to sell it globally without a big partner. That partner may or may not be BD. But I think he thinks a partner for it will materialize within the next several months who is willing to pay us what it is worth. Remember, he has Dr. Adam Simon coaching him. If you want to feel better about LymPro's potential for success, check out Dr. Simon. He is world renowned in Alzheimer's disease.